marcus evans north america conferences

12th Annual Pharma Resource Planning & Portfolio Management

Driving Strategic Decision Making to Better Optimize Resources and Maximize Portfolio ROI

6-7 Feb 2019
Philadelphia, PA, United States of America

Conference Workshop

Utilizing Predictive Technology to Extract Essential Data and Actionable Insights

In order to identify critical gaps, biopharmaceutical companies have utilized predictive technology to allow for operational and strategic improvements.

Workshop Moderator: Chris O’Donovan, Director, Resource Management R&D Business Insights & Analytics

Company: Bristol-Myers Squibb

Conference Workshop

Incorporating Tools & Frameworks for Improved Decision- Making to Balance Risk vs Reward

Decision-making continues to be a struggle for organizations within the Life Sciences space due to the amount of risks and uncertainty involved with each investment. Decision science provides consistent outcomes taking into account the risk versus the reward for a more effective way to make decisions.

Workshop Moderator: Nataraj Kalyanaraman, Director, R&D Transformation

Company:Bristol-Myers Squibb


Why You Should Attend

12th Annual Pharma Resource Planning & Portfolio Management

The pharmaceutical and biotechnology industries have fully embraced R&D portfolio management to ensure resources are allocated to winning projects. The huge investments, long development timelines, extreme high risk, and number of products in pipeline requires active management. The ability to determine real time decisions and assess prioritization is crucial in order to drive optimal performance.

This premier marcus evans event will bring together the foremost leaders within the resource planning and portfolio management divisions of Pharma and Biotech companies to identify new tools and strategies for better decision-making to successfully assess and manage global resources and portfolios.

Key Topics

  • Establish clarity in governance processes to achieve alignment
  • Maximize portfolio performance through machine learning and artificial intelligence
  • Enhance collaboration and communication for rapid change management
  • Implement a robust portfolio selection and prioritization process to enhance performance
  • Conduct risk assessments across portfolios to align strategic objectives
  • Previous Attendees Include

    Amgen, Astra Zeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb Company, Cora Systems, CSL Behring, Curium Pharmaceuticals, Daiichi Sankyo, Ferring, Halozyme Therapeutics, Innovate Biopharmaceuticals, Intarcia Therapeutics, Janssen Supply Group, Jazz Pharmaceuticals, Johnson & Johnson, Kite Pharma, Mallinckrodt Pharmaceuticals, Medimmune, Merck Animal Health, Nevakar, Pfizer, Sandoz, Takeda Pharmaceuticals, Teva Pharmaceuticals


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.






    Practical Insights From

    Kathy Olson, M.S., Ph.D.
    Vice President, R&D Global Portfolio & Project Management
    Pfizer Inc.

    Jared Fantasia
    Head, Global Portfolio & Project Management Operations
    Johnson & Johnson

    Javier Szwarcberg, MD, MPH
    Senior Vice President, Project & Portfolio Management
    Ultragenyx

    Simon Hornby
    Director, Portfolio & Resource Management Lead, Biometrics & Information Sciences
    AstraZeneca

    Trevor Landry, MBA
    Senior Director Portfolio Strategy and Mature Brands Commercial
    Novo Nordisk Inc.

    Nataraj Kalyanaraman
    Director, R&D Transformation
    Bristol-Myers Squibb

    Anesu H. Williams, DHSc., MPA
    Director, Portfolio Program Management
    AbbVie Inc.

    Click Here For Full Agenda

    Voice of Our Customers
    • "High quality presentations, engaging audience, well-run" - GSK Consumer
    • "The conference provided tremendous learning & networking opportunities in Portfolio Management" - Abbot Nutrition
    • "I would high recommend this conference, the speakers and presentations were of a very high caliberr and addressed major issues/topics on strategic resource of portfolio management" - Sunovion
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Melini Hadjitheori


    PO Box 24797
    CY-1304 Nicosia


    Telephone:
    +357 22 849 308
    Fax: +357 22 849 394
    Email: MeliniH@marcusevanscy.com